Transce3nd’s Zimmer Biomet ZBH Stock Holding History

Transce3nd’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$182	–	1182
2025 Q2	$182	Sell	2 -40	-95%	-$3.87K	﹤0.01%	1168
2025 Q1	$4.75K	Hold	42	–	–	﹤0.01%	739
2024 Q4	$4.44K	Buy	+42	New	+$4.51K	﹤0.01%	960

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Transce3nd's ZBH Position: Q3 2025 in Review

Transce3nd sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 2 shares — an estimated $182 sold.

Transce3nd first reported a position in ZBH in Q4 2024 and held it in 3 quarters. The position peaked at $4.75K in Q1 2025. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Transce3nd reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 2 Zimmer Biomet shares in Q3 2025, an estimated $182.
Transce3nd first reported a position in Zimmer Biomet in Q4 2024 and held it in 3 quarters.
Transce3nd's Zimmer Biomet position peaked at $4.75K in Q1 2025.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.